- Home
- DUO vs KAPA Comparison
DUO vs KAPA Comparison
Compare DUO & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DUO
- KAPA
- Stock Information
- Founded
- DUO 2011
- KAPA 2013
- Country
- DUO China
- KAPA United States
- Employees
- DUO N/A
- KAPA N/A
- Industry
- DUO Real Estate
- KAPA
- Sector
- DUO Finance
- KAPA
- Exchange
- DUO Nasdaq
- KAPA NYSE
- Market Cap
- DUO 17.1M
- KAPA 18.8M
- IPO Year
- DUO 2019
- KAPA 2024
- Fundamental
- Price
- DUO $0.58
- KAPA $1.27
- Analyst Decision
- DUO
- KAPA Strong Buy
- Analyst Count
- DUO 0
- KAPA 1
- Target Price
- DUO N/A
- KAPA $9.00
- AVG Volume (30 Days)
- DUO 4.3M
- KAPA 969.6K
- Earning Date
- DUO 04-17-2025
- KAPA 03-04-2025
- Dividend Yield
- DUO N/A
- KAPA N/A
- EPS Growth
- DUO N/A
- KAPA N/A
- EPS
- DUO N/A
- KAPA N/A
- Revenue
- DUO $37,352,654.00
- KAPA N/A
- Revenue This Year
- DUO N/A
- KAPA N/A
- Revenue Next Year
- DUO N/A
- KAPA N/A
- P/E Ratio
- DUO N/A
- KAPA N/A
- Revenue Growth
- DUO 6.61
- KAPA N/A
- 52 Week Low
- DUO $0.32
- KAPA $0.85
- 52 Week High
- DUO $4.67
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- DUO 46.49
- KAPA N/A
- Support Level
- DUO $0.57
- KAPA N/A
- Resistance Level
- DUO $0.67
- KAPA N/A
- Average True Range (ATR)
- DUO 0.04
- KAPA 0.00
- MACD
- DUO 0.00
- KAPA 0.00
- Stochastic Oscillator
- DUO 12.40
- KAPA 0.00
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. Through its subsidiaries, It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.